Ceftazidime-avibactam-resistant Klebsiella pneumoniae driven by multiple β-lactamase mutations: a hospital outbreak report
Clinical Microbiology and Infection · 2026
DOI: 10.1016/j.cmi.2026.03.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2026. Verfasst von Weiwei Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China; Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of He…. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Ceftazidime, beta-Lactamases, Klebsiella Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: Pfizer, National Natural Science Foundation of China.
Abstract (Originalsprache)
OBJECTIVES: This study aimed to trace the clonal dissemination of ceftazidime-avibactam-resistant Klebsiella pneumoniae and clarify the complex ceftazidime-avibactam resistance mechanism caused by multiple β-lactamase variants. METHODS: Six ceftazidime-avibactam-resistant K. pneumoniae clinical strains were isolated from six inpatients in the hepatobiliary surgery department. The antimicrobial resistance phenotypes, genotypes and single nucleotide polymorphisms of the strains were analysed. The resistance mechanism of K. pneumoniae strains to ceftazidime-avibactam was clarified through molecular cloning and enzyme kinetic measurement. The transferability of ceftazidime-avibactam resistance in the strains was verified by conjugation test, S1 pulsed field gel electrophoresis and plasmid sequence analysis. Fitness was determined using bacterial growth curves and plasmid stability tests. RESULTS: The number of single nucleotide polymorphisms in all six K. pneumoniae strains was less than six, indicating a nosocomial clonal dissemination incident. K. pneumoniae carbapenemase 157 is unable to mediate resistance to ceftazidime-avibactam. The variant CTX-M-249, which mutated from CTX-M-65 (Ser130Gly and Pro167Ser), could mediate resistance to ceftazidime-avibactam, because avibactam alone could not efficiently inhibit enzyme activity. Under the selective pressure of ceftazidime-avibactam, a plasmid carrying blaCTX-M-249 was transferred into a recipient cell. Based on analysis of the genomic evolution and medical history, the selective pressure exerted by ceftazidime-avibactam during transmission may have contributed to the mutation, replication and truncation of the gene region conferring resistance, especially in the complex evolution of blaCTX-M-65. The coexistence of blaCTX-M-65 and blaCTX-M-249 alleles on different plasmids may have evolved into two copies of blaCTX-M-249, enhancing the resistance to ceftazidime-avibactam. CONCLUSIONS: This study reports the clonal dissemination of K. pneumoniae carbapenemase 157-producing ceftazidime-avibactam-resistant K. pneumoniae strains and reveals the resistance mechanism of a novel bla variant, CTX-M-249 for the first time, to our knowledge. The dissemination of these mutant strains poses an alarm for global infection prevention and control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China; Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health, Shanghai, China.
- Clinical Laboratory, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of General Surgery, Hepatobiliary Surgery Center, Huashan Hospital, Fudan University, Shanghai, China. Electronic address: jinhongch@hotmail.com.
- Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China; Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health, Shanghai, China; Joint Laboratory of Hospital & Enterprise for P…
Förderung
- Pfizer
- National Natural Science Foundation of China
Zitieren
APA
Yang, W., Tang, C., Shi, Q., Ou, H., Yin, D., Han, R., Chen, J., Guo, Y., & Hu, F. (2026). Ceftazidime-avibactam-resistant Klebsiella pneumoniae driven by multiple β-lactamase mutations: a hospital outbreak report. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2026.03.014
Vancouver
Yang W, Tang C, Shi Q, Ou H, Yin D, Han R, et al. Ceftazidime-avibactam-resistant Klebsiella pneumoniae driven by multiple β-lactamase mutations: a hospital outbreak report. Clinical Microbiology and Infection. 2026. doi:10.1016/j.cmi.2026.03.014
BibTeX
@article{Yang2026,
author = {Yang, Weiwei and Tang, Chengkang and Shi, Qingyu and Ou, Hongjian and Yin, Dandan and Han, Renru and Chen, Jinhong and Guo, Yan and Hu, Fupin},
title = {Ceftazidime-avibactam-resistant Klebsiella pneumoniae driven by multiple β-lactamase mutations: a hospital outbreak report},
journal = {Clinical Microbiology and Infection},
year = {2026},
doi = {10.1016/j.cmi.2026.03.014}
}
EUVIMED